Literature DB >> 18090653

Age, alcohol metabolism and liver disease.

Patrick Meier1, Helmut K Seitz.   

Abstract

PURPOSE OF REVIEW: Alcohol consumption among the elderly has increased. Alcohol metabolism changes with age and the elderly are more sensitive to the toxic effects; this increased consumption is therefore of great clinical relevance. RECENT
FINDINGS: Metabolism of ethanol changes with advancing age because activity of the enzymes involved, such as alcohol and acetaldehyde dehydrogenase and cytochrome P-4502E1, diminish with age. The water distribution volume also decreases with age. Both lead to increased blood concentrations of ethanol. Also, elderly people take more drugs, and ethanol and these drugs may interact; therefore, alcohol consumption can modify serum drug concentrations and their toxicity. Finally, elderly people may suffer more frequently from other types of liver disease, and alcohol may exacerbate these.
SUMMARY: Over recent decades alcohol consumption has increased among those who are older than 65 years. Alcohol is more toxic in the ageing organism because of changes in its metabolism, distribution and elimination, which lead to central nervous system effects at lower levels of intake; also, ageing organs such as brain and liver are more sensitive to the toxicity of alcohol. For these reasons, alcohol should be used in moderation, especially among those of older age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18090653     DOI: 10.1097/MCO.0b013e3282f30564

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  53 in total

1.  Summary of the 2017 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Holly J Hulsebus; Brenda J Curtis; Patricia E Molina; Majid Afshar; Lisbeth A Boule; Niya Morris; Ali Keshavarzian; Jay K Kolls; Samantha M Yeligar; Michael E Price; Todd A Wyatt; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2017-10-31       Impact factor: 2.405

Review 2.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Binxia Chang; Michael J Duryee; Geoffrey E Thiele; Akiko Matsumoto; Surendra Singh; Mohamed A Abdelmegeed; Byoung-Joon Song; Toshihiro Kawamoto; Vasilis Vasiliou; Geoffrey M Thiele; Bin Gao
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

Review 4.  Aging and liver disease.

Authors:  In Hee Kim; Tatiana Kisseleva; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

5.  Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.

Authors:  Teresa Ramirez; Yong-Mei Li; Shi Yin; Ming-Jiang Xu; Dechun Feng; Zhou Zhou; Mengwei Zang; Partha Mukhopadhyay; Zoltan V Varga; Pal Pacher; Bin Gao; Hua Wang
Journal:  J Hepatol       Date:  2016-11-18       Impact factor: 25.083

6.  Chunggan extract, a traditional herbal formula, ameliorated alcohol-induced hepatic injury in rat model.

Authors:  Hyeong-Geug Kim; Jung-Min Kim; Jong-Min Han; Jin-Seok Lee; Min-Kyung Choi; Dong-Soo Lee; Yeon-Hwa Park; Chang-Gue Son
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.

Authors:  Dimitrios Stagos; Ying Chen; Chad Brocker; Elizabeth Donald; Brian C Jackson; David J Orlicky; David C Thompson; Vasilis Vasiliou
Journal:  Drug Metab Dispos       Date:  2010-07-08       Impact factor: 3.922

Review 8.  Liver disease, HIV and aging.

Authors:  Oluwaseun Falade-Nwulia; Chloe L Thio
Journal:  Sex Health       Date:  2011-12       Impact factor: 2.706

9.  Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis Care.

Authors:  Raj K Kalapatapu; R Chambers
Journal:  J Dual Diagn       Date:  2009-01-01

10.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines.

Authors:  Zheng Shen; Joanne M Ajmo; Christopher Q Rogers; Xiaomei Liang; Lisa Le; Michel M Murr; Yanhua Peng; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.